Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Flare Therapeutics Announces Initiation of Phase 1B Study of FX-909 for Treatment of Metastatic Urothelial Cancer
-
Creative Realities Deploys Digital Display Solution at Circle K Mexico to Drive Sales and Advance Sustainability Efforts
-
Prairie Operating Co. Announces Second Quarter 2025 Earnings Release Date and Conference Call
-
Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August 12, 2025
-
Hillman’s Board of Directors Approves $100 Million Share Repurchase Program
-
Exodus Movement, Inc. July 2025 Treasury Update and Monthly Metrics
-
Judge Recognized by Staffing Industry Analysts on Multiple 2025 Industry Lists
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Neuronetics Reports Second Quarter 2025 Financial and Operating Results
-
Xometry Reports Record Second Quarter 2025 Results
-
Adaptec® SmartRAID 4300 Series of Accelerators Deliver Scalable, Secure NVMe® RAID Storage Solutions
-
Kaldalón hf.: Routine Announcement Regarding Share Buybacks Pursuant to Buyback Program
-
Forsys Announces Commencement of Expansion Drill Program at Namibplaas
-
SynOx Therapeutics Completes Enrollment in Registrational Phase 3 TANGENT Clinical Trial Significantly Ahead of Timeline
-
J & J Snack Foods Reports Fiscal 2025 Third Quarter Results
-
Ocular Therapeutix™ Reports Second Quarter 2025 Financial Results and Business Highlights
-
Enviri Corporation Reports Second Quarter 2025 Results
-
Sportradar Reports Second Quarter Financial Results and Raises Full Year 2025 Outlook
-
Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates
-
Sachem Capital Reports Second Quarter 2025 Results
-
First Watch Restaurant Group, Inc. Reports Q2 2025 Financial Results and Reaches 600th System-Wide Restaurant Milestone
-
Xtract One Chosen by Volusia County Schools to Advance School Safety
-
Ontario Media Advisory: MADD Canada and its Local Chapter MADD Windsor & Essex County to Unveil Memorial Garden in Honour of Victims and Survivors of Crashes Involving Alcohol and/or Drugs
-
Tango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
-
English Speakers Left Out — Again — of Québec’s 2025-2026 Employment Services Strategy
-
FUNDAMENTAL GLOBAL INC. SUCCESSFULLY CLOSES $200 MILLION PRIVATE PLACEMENT TO ACCELERATE ETHEREUM TREASURY STRATEGY
-
Blade Air Mobility Announces Second Quarter 2025 Results
-
Rhythm Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Update
-
Axogen, Inc. Reports Second Quarter 2025 Financial Results
-
LGI Homes, Inc. Reports Second Quarter 2025 Results
-
Vera Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
-
Shoals Technologies Group, Inc. Reports Financial Results for Second Quarter 2025
-
Symbotic Unveils Next-Generation Storage for its Warehouse Automation System – Enabling Significantly Reduced Customer Footprint and Faster Case Handling
-
CareCloud Reports Second Quarter 2025 Results
-
Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights
-
Cibus to Report Second Quarter 2025 Financial Results on August 14, 2025 After the Market Close and Host Conference Call
-
EVgo Inc. Reports Record Second Quarter 2025 Results
-
Beam Therapeutics Reports Second Quarter 2025 Financial Results and Provides Update on BEAM-302 Development Progress in Alpha-1 Antitrypsin Deficiency (AATD)
-
PyroGenesis Signs Additional Contract with Constellium to Advance Aluminum Furnace Electrification Using Plasma Torch Technology
-
Bitfarms Announces Partnership with T5 Data Centers to Advance HPC/AI Development at Panther Creek Campus
-
Foghorn Therapeutics Provides Second Quarter 2025 Financial and Corporate Update
-
Sagimet Biosciences to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
GlobalFoundries Reports Second Quarter 2025 Financial Results
-
Iterum Therapeutics Reports Second Quarter 2025 Financial Results
-
Elicio Therapeutics Announces Positive Recommendation by IDMC to Continue ELI-002 7P Randomized Phase 2 Study in Pancreatic Cancer Without Modifications to Final Analysis
-
Envision Pharma Group appoints Tom Langan as Chief Executive Officer
-
MoonLake Immunotherapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update
-
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
-
Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings
-
TEN Protocol Launches Community-First Raise: Infrastructure Ownership for the Next Era of Ethereum
